{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:43:55Z","timestamp":1773863035976,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ashjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jash.2016.01.006","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T01:15:39Z","timestamp":1452474939000},"page":"244-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Differential effects of enalapril\u2013felodipine versus enalapril\u2013lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension"],"prefix":"10.1016","volume":"10","author":[{"given":"Gino","family":"Seravalle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmaria","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Prata","family":"Pizzalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Casati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Riva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Cuspidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8459-711X","authenticated-orcid":false,"given":"Michele","family":"Bombelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Mancia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jash.2016.01.006_bib1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00004872-199917080-00012","article-title":"Neural mechanisms in human obesity-related hypertension","volume":"17","author":"Rumantir","year":"1999","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.jash.2016.01.006_bib2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.HYP.36.4.538","article-title":"Adrenergic and reflex abnormalities in obesity-related hypertension","volume":"36","author":"Grassi","year":"2000","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.jash.2016.01.006_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.HYP.0000151325.83008.b4","article-title":"Obesity-associated hypertension: new insights into mechanisms","volume":"45","author":"Rahmouni","year":"2005","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.jash.2016.01.006_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.0000242642.42177.49","article-title":"Mechanisms of sympathetic activation in obesity-related hypertension","volume":"48","author":"Esler","year":"2006","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.jash.2016.01.006_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jash.2009.10.001","article-title":"The complex interaction between overweight, obesity and the sympathetic nervous system","volume":"3","author":"Feldstein","year":"2009","journal-title":"J Am Soc Hypertens"},{"issue":"28","key":"10.1016\/j.jash.2016.01.006_bib6","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jash.2016.01.006_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jash.2014.12.015","article-title":"Treatment: special conditions. Metabolic syndrome: obesity and the hypertension connection","volume":"9","author":"Reisin","year":"2015","journal-title":"J Am Soc Hypertens"},{"issue":"6","key":"10.1016\/j.jash.2016.01.006_bib8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCRESAHA.116.303604","article-title":"The sympathetic nervous system alterations in human hypertension","volume":"116","author":"Grassi","year":"2015","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.jash.2016.01.006_bib9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-related hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.jash.2016.01.006_bib10","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1161\/CIRCRESAHA.114.302524","article-title":"The autonomic nervous system and hypertension","volume":"114","author":"Mancia","year":"2014","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.jash.2016.01.006_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"10.1016\/j.jash.2016.01.006_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0894-7317(96)90019-X","article-title":"Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography","volume":"9","author":"Park","year":"1996","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"10.1016\/j.jash.2016.01.006_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.HYP.0000058003.27729.5A","article-title":"Short- versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension","volume":"41","author":"Grassi","year":"2003","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.jash.2016.01.006_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0024-3205(79)90384-9","article-title":"Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method","volume":"25","author":"Hjemdahl","year":"1979","journal-title":"Life Sci"},{"issue":"7","key":"10.1016\/j.jash.2016.01.006_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.jash.2016.01.006_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.HYP.20.2.227","article-title":"Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-h intraarterial blood pressure","volume":"20","author":"Groppelli","year":"1992","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.jash.2016.01.006_bib17","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.2337\/dc06-1373","article-title":"Differences in glucose tolerance between fixed dose antihypertensive drug combinations in people with metabolic syndrome","volume":"29","author":"Bakris","year":"2006","journal-title":"Diab Care"},{"key":"10.1016\/j.jash.2016.01.006_bib18","series-title":"Handbook of Physiology: The Cardiovascular System","first-page":"755","article-title":"Arterial baroreflex in humans","author":"Mancia","year":"1983"},{"issue":"2","key":"10.1016\/j.jash.2016.01.006_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00003495-199244020-00008","article-title":"Felodipine: a review of the pharmacological and therapeutic use of the extend release formulations in cardiovascular disorders","volume":"44","author":"Todd","year":"1992","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.jash.2016.01.006_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00192375","article-title":"Clinical equivalence of two tablet formulations of felodipine: a placebo controlled study of 24-hour blood pressure control and tolerability","volume":"49","author":"McGrath","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.jash.2016.01.006_bib21","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1097\/00004872-199816120-00017","article-title":"Antihypertensive efficacy of lercanidipine at 2.5, 5, and 10 mg in mild-to-moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators","volume":"16","author":"Omboni","year":"1998","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.jash.2016.01.006_bib22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2165\/00003495-200060050-00009","article-title":"Lercanidipine: a review of its using in hypertension","volume":"60","author":"McClellan","year":"2000","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.jash.2016.01.006_bib23","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1097\/HJH.0000000000000270","article-title":"Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension","volume":"32","author":"Inomata","year":"2014","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.jash.2016.01.006_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00041552-200409000-00006","article-title":"Counteracting the sympathetic nervous system in hypertension","volume":"13","author":"Grassi","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"10.1016\/j.jash.2016.01.006_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/HYPERTENSIONAHA.112.194787","article-title":"Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients","volume":"60","author":"Raheja","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.jash.2016.01.006_bib26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/HJH.0b013e32835b6c02","article-title":"Differential effects of renin-angiotensin system inhibition, sympathoinhibition and blood pressure in obesity-related hypertension: a double-blind, placebo controlled cross-over trial","volume":"31","author":"Dorresteijn","year":"2013","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.jash.2016.01.006_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/14779072.2015.986464","article-title":"Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders","volume":"13","author":"Shimada","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"10.1016\/j.jash.2016.01.006_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/08037051.2014.901021","article-title":"Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study","volume":"23","author":"De Ciuceis","year":"2014","journal-title":"Blood Press"},{"issue":"8","key":"10.1016\/j.jash.2016.01.006_bib29","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1097\/HJH.0000000000000239","article-title":"Effects on office and home blood pressure of the lercanidipine\/enalapril combination in patients with stage 2 hypertension: a European randomized controlled trial","volume":"32","author":"Mancia","year":"2014","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.jash.2016.01.006_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0149-2918(98)80062-3","article-title":"Long-term efficacy, tolerability and safety of the combination enalapril and felodipine in the treatment of hypertension. Enalapril-Felodipine Factorial Study Group","volume":"20","author":"Gradman","year":"1998","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.jash.2016.01.006_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003495-200767010-00007","article-title":"Fixed-dose combination Lercanidipine-Enalapril","volume":"67","author":"Hair","year":"2007","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.jash.2016.01.006_bib32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00004872-199816090-00017","article-title":"Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients","volume":"16","author":"De Champlain","year":"1998","journal-title":"J Hypertens"},{"issue":"11","key":"10.1016\/j.jash.2016.01.006_bib33","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/00004872-199816110-00010","article-title":"Heart rate as marker of sympathetic activity","volume":"16","author":"Grassi","year":"1998","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.jash.2016.01.006_bib34","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.302549","article-title":"Role of the autonomic nervous system in modulating cardiac arrhythmias","volume":"114","author":"Shen","year":"2014","journal-title":"Circ Res"}],"updated-by":[{"DOI":"10.1016\/j.jash.2017.06.010","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000}}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171116000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171116000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T04:21:05Z","timestamp":1537071665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171116000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1933171116000073"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2016.01.006","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jash.2017.06.010","asserted-by":"object"}]},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effects of enalapril\u2013felodipine versus enalapril\u2013lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jash.2016.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}